China has announced recent regulatory changes targeting specific industries, which has led to some heighted market volatility. Franklin Templeton’s Emerging Markets Equity team examines what the changes are, why they were implemented, and the potential implications for investors. READ MORE
Similar Posts:
- China’s Regulatory Tightening: Our View on Goals and Scope (Franklin Templeton)
- Evergrande and China: A Lehman Moment—or Less “Grande” Than That? (Franklin Templeton)
- Health Care: The Next Wave of Innovation in China (Franklin Templeton)
- The New Emerging Markets Landscape: Policy Improvements Should Contribute to Increased Resilience (Franklin Templeton)
- Evergrande Crisis and Contagion Risks (Franklin Templeton)
- The Race to Harness AI Technology in Asia (Franklin Templeton)
- Emerging Markets Experience a Volatile First Quarter (Franklin Templeton Investments)
- Russia, Ukraine and China (Franklin Templeton)
- Templeton’s Chow: “No Reason the Goat and the Bull Cannot be Friends” (Mobius Blog)
- October EM Market Recap and Outlook: A Sea of Opportunities (Franklin Templeton)
- The New Emerging Market Landscape: The Single Commodity Focus Has Shifted (Franklin Templeton)
- Changes to the Emerging Markets Club: China (A Shares), Argentina and Saudi Arabia (Franklin Templeton)
- Dr. Mark Mobius Announces Plans to Retire from Franklin Templeton Investments
- South Korea: A Shining Example of Emerging Market Leadership (Franklin Templeton)
- MENA Equities: Why Long-Term Investors Should Stay the Course (Franklin Templeton)
